Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate
2007-08-28
2007-08-28
Saoud, Christine J. (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
C424S085100, C514S002600, C514S012200, C530S300000, C530S350000
Reexamination Certificate
active
10742641
ABSTRACT:
Methods of treating pain by delivery of anti-inflammatory cytokines, proinflammatory cytokine antagonists, and agents that act to reduce or prevent proinflammatory cytokine actions, to the nervous system are described. These agents can be delivered using gene therapy techniques. Alternatively, the agents can be delivered in protein compositions.
REFERENCES:
patent: 5231012 (1993-07-01), Mosmann et al.
patent: 6018036 (2000-01-01), Mosmann et al.
patent: 6217857 (2001-04-01), Mosmann et al.
patent: 6403077 (2002-06-01), Strom et al.
patent: 6413942 (2002-07-01), Felgner et al.
patent: 6428985 (2002-08-01), Bromberg et al.
patent: 2003/0044384 (2003-03-01), Roberts et al.
patent: 2003/0049256 (2003-03-01), Tobinick
patent: WO9404180 (1994-03-01), None
patent: WO99/47157 (1999-09-01), None
patent: WO99/56784 (1999-11-01), None
Vakaet, et al Int. J. Dev. Biol. 48: 599-606, ‘Pain control by ionizing radiation of bone metastasis’.
Wagner et al. (1998). Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain. 74:35-42.
Pettit et al. (1998). The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals. Trends Biotechnol 16:343-349.
Miller, G. (2002). Breaking down barriers. Science 297:1116-1118.
Cua et al., “Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis,” J. Immunology, Jan. 2001, vol. 166, pp. 603-608.
Andreansky et al., “Treatment of Intracranial Gliomas in Immunocompetent Mice using Herpes Simplex Viruses that Express Murine Interleukins,” Gene Therapy, Jan. 1998, vol. 5, pp. 121-130.
Jiang et al., “Sustained Expression of Fc-Fusion Cytokine Following In Vivo Electroporation and Mouse Strain Differences in Expression Levels,”J. Biochem, 133:423-427 (2003).
Adachi, O. et al., “Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis,” Gene Therapy 9:577-583 (2002).
Yao et al., “Interleukin-2 gene has superior antinociceptive effects when delivered intrathecally”Clinical Neuroscience and Neuropathology13(6):791-794 (2002).
Lockard Jon M
Reagents of the University of Colorado
Robins & Pasternak LLP
Saoud Christine J.
LandOfFree
Methods for treating neuropathic pain by administering IL-10... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating neuropathic pain by administering IL-10..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating neuropathic pain by administering IL-10... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3838331